Logo image of NU.CA

NEUTRISCI INTERNATIONAL INC (NU.CA) Stock Fundamental Analysis

TSX-V:NU - TSX Venture Exchange - CA64129Y1079 - Common Stock - Currency: CAD

0.005  0 (0%)

Fundamental Rating

1

NU gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 5 industry peers in the Personal Care Products industry. Both the profitability and financial health of NU have multiple concerns. NU has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

NU had negative earnings in the past year.
NU had a negative operating cash flow in the past year.
In the past 5 years NU always reported negative net income.
In the past 5 years NU always reported negative operating cash flow.
NU.CA Yearly Net Income VS EBIT VS OCF VS FCFNU.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 -1M -2M -3M

1.2 Ratios

With a Return On Assets value of -432.18%, NU is not doing good in the industry: 60.00% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -432.18%
ROE N/A
ROIC N/A
ROA(3y)-264.66%
ROA(5y)-308.79%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NU.CA Yearly ROA, ROE, ROICNU.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 0 2K -2K -4K -6K -8K

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for NU so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NU.CA Yearly Profit, Operating, Gross MarginsNU.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 0 -5K -10K -15K

More info and screens

0

2. Health

2.1 Basic Checks

NU does not have a ROIC to compare to the WACC, probably because it is not profitable.
NU has more shares outstanding than it did 1 year ago.
The debt/assets ratio for NU is higher compared to a year ago.
NU.CA Yearly Shares OutstandingNU.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 50M 100M 150M
NU.CA Yearly Total Debt VS Total AssetsNU.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 500K 1M 1.5M

2.2 Solvency

NU has an Altman-Z score of -422.87. This is a bad value and indicates that NU is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -422.87, NU is not doing good in the industry: 60.00% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -422.87
ROIC/WACCN/A
WACC7.56%
NU.CA Yearly LT Debt VS Equity VS FCFNU.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 500K -500K -1M -1.5M -2M

2.3 Liquidity

NU has a Current Ratio of 0.02. This is a bad value and indicates that NU is not financially healthy enough and could expect problems in meeting its short term obligations.
NU's Current ratio of 0.02 is on the low side compared to the rest of the industry. NU is outperformed by 80.00% of its industry peers.
A Quick Ratio of 0.01 indicates that NU may have some problems paying its short term obligations.
NU has a worse Quick ratio (0.01) than 80.00% of its industry peers.
Industry RankSector Rank
Current Ratio 0.02
Quick Ratio 0.01
NU.CA Yearly Current Assets VS Current LiabilitesNU.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 500K 1M 1.5M

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 42.21% over the past year.
Looking at the last year, NU shows a very negative growth in Revenue. The Revenue has decreased by -86.13% in the last year.
The Revenue has been growing by 24.82% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)42.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%12.7%
Revenue 1Y (TTM)-86.13%
Revenue growth 3Y68%
Revenue growth 5Y24.82%
Sales Q2Q%-46.99%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NU.CA Yearly Revenue VS EstimatesNU.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 100K 200K 300K 400K

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A
NU.CA Price Earnings VS Forward Price EarningsNU.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NU.CA Per share dataNU.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0 -0 -0 -0 -0

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for NU!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

NEUTRISCI INTERNATIONAL INC

TSX-V:NU (5/7/2024, 7:00:00 PM)

0.005

0 (0%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners1.29%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap892.12K
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 14.87
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)0
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0
FCFYN/A
OCF(TTM)0
OCFYN/A
SpS0
BVpS-0.01
TBVpS-0.01
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -432.18%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-264.66%
ROA(5y)-308.79%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score1
Asset Turnover0.47
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 0%
Cap/Sales 0%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.02
Quick Ratio 0.01
Altman-Z -422.87
F-Score1
WACC7.56%
ROIC/WACCN/A
Cap/Depr(3y)218.54%
Cap/Depr(5y)279.44%
Cap/Sales(3y)94%
Cap/Sales(5y)63.22%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)42.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%12.7%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-86.13%
Revenue growth 3Y68%
Revenue growth 5Y24.82%
Sales Q2Q%-46.99%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y37.35%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y77.41%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y74.07%
OCF growth 3YN/A
OCF growth 5YN/A